Treatment Options for Interstitial Cystitis/Bladder Pain Syndrome
Treatment for interstitial cystitis/bladder pain syndrome (IC/BPS) should follow a multi-modal approach, beginning with conservative therapies and progressing to more invasive options only when symptom control is inadequate for acceptable quality of life. 1
Diagnosis Considerations
Before initiating treatment, proper diagnosis is essential:
- Symptoms should be present for at least 6 weeks with documented negative urine cultures
- Cystoscopy is indicated when Hunner lesions are suspected, as they require specific treatment 1
- Urodynamic studies are not routinely recommended but may be useful in specific cases 1
Treatment Algorithm
First-Line: Behavioral/Non-Pharmacologic Approaches
- Self-care practices and behavioral modifications:
- Dietary modifications: Identify and avoid bladder irritants (coffee, citrus, spicy foods)
- Fluid management: Alter concentration/volume of urine through hydration adjustments
- Stress management techniques to manage flare-ups (meditation, imagery)
- Application of heat or cold over bladder or perineum
- Pelvic floor muscle relaxation
- Bladder training with urge suppression 1
Second-Line: Oral Medications
- Amitriptyline (Grade B evidence): Start at low doses (10mg) and titrate gradually to 75-100mg if tolerated 1
- Cimetidine (Grade B evidence): Shown to improve symptoms, pain, and nocturia 1
- Hydroxyzine (Grade C evidence): May be particularly effective in patients with systemic allergies 1
- Pentosan polysulfate (PPS) (Grade B evidence): The only FDA-approved oral medication for IC/BPS 1
Second-Line: Intravesical Treatments
- Dimethyl sulfoxide (DMSO) instillation:
- FDA-approved for IC/BPS
- Protocol: 50mL instilled directly into bladder, retained for 15 minutes, repeated every 2 weeks until maximum relief is obtained 3
- Pre-treatment with lidocaine jelly and/or oral analgesics may reduce discomfort 3
- Note: Patients will experience garlic-like taste and odor that may last up to 72 hours 3
- Heparin instillation
- Lidocaine instillation 1
Third/Fourth-Line: Procedures
- Cystoscopy with hydrodistension (low pressure, short duration only)
- Botulinum toxin A (100U) for patients who fail conservative therapies
- Patients must accept possibility of needing intermittent self-catheterization
- Not appropriate for patients who cannot tolerate catheterization 1
Last Resort: Surgical Options
- Should only be considered after all other treatment options have been exhausted
- May include urinary diversion with or without cystectomy 1
Treatment Pitfalls and Caveats
Avoid high-pressure, long-duration hydrodistension due to risk of serious adverse events including bladder rupture 1
Avoid long-term systemic glucocorticoids due to serious adverse events and known risks 1
Monitor patients on pentosan polysulfate for vision changes, as it has been associated with macular damage 1
Recognize treatment limitations:
Pain management alone is insufficient - it should be one component of a comprehensive treatment approach 1
Special Considerations
- For patients with Hunner lesions, fulguration is appropriate at any stage of treatment 1
- For patients with very sensitive bladders, initial intravesical treatments may need to be done under anesthesia 3
- Treatment should be adjusted based on symptom severity and patient response
IC/BPS is a chronic condition requiring ongoing management. While there is no cure, most patients can achieve significant symptom improvement with appropriate treatment.